Prometrium Missed-Dose Protocol: What to Do When You Skip Micronized Progesterone

At a glance
- Generic name / micronized progesterone (brand: Prometrium)
- Standard HRT dose / 200 mg orally at bedtime for 12 days per cycle (cyclic) or 100 mg nightly (continuous)
- Half-life / approximately 16 to 18 hours after oral dosing
- Missed-dose window / take the same day if remembered; skip if next dose is within 8 hours
- Endometrial risk threshold / missing 3 or more consecutive doses in a 12-day cycle may reduce protection
- FDA-approved indication / prevention of endometrial hyperplasia in postmenopausal women on conjugated estrogens
- Key safety trial / PEPI (1995), 875 women, 3-year follow-up
- Food effect / taking with food increases peak plasma levels by roughly 2-fold vs. fasting
- Sedation note / bedtime dosing recommended due to progesterone's neurosteroid metabolite allopregnanolone
How Prometrium Works: The Mechanism Behind Micronized Progesterone
Prometrium delivers bioidentical progesterone, micronized into fine particles suspended in peanut oil to improve oral absorption. Once absorbed, progesterone binds nuclear progesterone receptors (PR-A and PR-B) in the endometrial lining, converting proliferative tissue driven by estrogen into a secretory state 1. This secretory transformation is the primary defense against endometrial hyperplasia in women using estrogen-based hormone replacement therapy.
The drug undergoes extensive first-pass hepatic metabolism, producing the neuroactive metabolite allopregnanolone. This metabolite acts on GABA-A receptors, which explains the drowsiness many women report within 1 to 3 hours of dosing 2. That sedation is not a side effect to fight. It is the reason prescribers direct patients to take Prometrium at bedtime.
Oral micronized progesterone differs from synthetic progestins like medroxyprogesterone acetate (MPA) in a clinically meaningful way. The PEPI trial (N=875) demonstrated that women taking micronized progesterone preserved their HDL cholesterol levels, while those on MPA experienced a statistically significant HDL decrease of 1.2 mg/dL compared to baseline at 36 months 1. The Endocrine Society's 2015 clinical practice guideline notes that "micronized progesterone may be preferred over medroxyprogesterone acetate for endometrial protection because of a more favorable effect on the lipid profile" 3.
The Standard Dosing Regimen: What You Are Supposed to Take
Before addressing missed doses, the prescribed regimen matters. Two patterns dominate clinical practice.
In cyclic dosing, 200 mg is taken orally at bedtime for 12 consecutive days each calendar month (days 1 through 12, or days 15 through 26, depending on the prescriber's preference). The remaining days of the month are progesterone-free. This pattern typically produces a withdrawal bleed, which confirms adequate endometrial shedding 4.
In continuous-combined dosing, 100 mg is taken nightly without interruption, paired with daily estrogen. This approach aims to prevent breakthrough bleeding after the first 3 to 6 months of therapy and is common in women who are several years past menopause 5.
The FDA-approved labeling for Prometrium specifies the cyclic 200 mg regimen for endometrial protection in combination with conjugated estrogens 0.625 mg daily 4. The continuous 100 mg approach, while widely used, is considered off-label for endometrial protection and is based on observational data and expert consensus.
Step-by-Step: What to Do When You Miss a Dose
The half-life of oral micronized progesterone ranges from 16 to 18 hours, which creates a practical decision window 2.
If you remember within the same day (say, the following morning after a missed bedtime dose): take the capsule immediately. Expect drowsiness. If you have work or need to drive, wait until your next bedtime dose and accept the single skip.
If your next dose is within 8 hours: skip the missed dose entirely. Taking two doses close together will roughly double peak allopregnanolone levels, producing significant sedation, dizziness, and possible next-morning impairment 6.
Never double the dose. The Prometrium prescribing information states directly: "If a dose is missed, it should be taken as soon as remembered. If it is almost time for the next dose, the missed dose should be skipped" 4.
If you miss two or more consecutive doses in a cyclic regimen: contact your prescriber before resuming. Two skipped doses out of a 12-day cycle means you have delivered progesterone for only 10 of the required days, which may fall below the minimum duration (10 days) the PEPI trial validated for endometrial protection 1.
Why Consecutive Missed Doses Are Clinically Risky
A single skipped dose of Prometrium is unlikely to cause endometrial harm. The concern compounds with consecutive misses, and the math is straightforward.
Estrogen drives endometrial cell proliferation. Progesterone stops that proliferation and converts the tissue to a secretory state. The PEPI trial demonstrated that 12 days of micronized progesterone (200 mg/day) per cycle reduced endometrial hyperplasia rates to 0.8% at 3 years, compared to 10% in the unopposed estrogen group 1. The critical variable was duration of progesterone exposure per cycle, not the peak blood level on any single day.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) consensus statement specifies that "a minimum of 10 days of progestogen per cycle is required for adequate endometrial protection" 7. Missing 3 doses from a 12-day cycle drops exposure to 9 days, which sits below that minimum.
For women on continuous 100 mg dosing, the risk calculation differs. One missed night is a brief gap in a daily regimen. But 3 or more consecutive missed days while continuing daily estrogen creates a period of unopposed estrogen exposure, and the endometrium can begin proliferative changes within 48 to 72 hours of progesterone withdrawal 8.
Timing and Food: Factors That Affect Absorption
Even when you take Prometrium on schedule, absorption varies by 2-fold or more depending on whether you ate recently. The prescribing information reports that administration with food increases the area under the curve (AUC) of progesterone relative to fasting by approximately 2-fold 4. A high-fat meal amplifies this effect further.
The clinical implication for missed doses: if you take a remembered dose in the morning on an empty stomach, you may absorb roughly half the progesterone compared to your usual bedtime dose taken after dinner. This is still better than skipping entirely, but it explains why some women notice spotting or breakthrough bleeding after taking a "make-up" dose at an unusual time.
Dr. JoAnn V. Pinkerton, past president of the North American Menopause Society, has stated: "Consistency in timing and food intake with micronized progesterone matters more than most patients realize. Taking it at the same time each evening, ideally after a meal, optimizes both absorption and the sleep benefit from allopregnanolone" 9.
Prometrium vs. Synthetic Progestins: Does the Missed-Dose Rule Differ?
The missed-dose logic is similar across progestogens, but the consequences differ. Synthetic progestins like MPA (Provera) and norethindrone acetate have longer half-lives (12 to 24 hours for MPA, 6 to 10 hours for norethindrone) and higher receptor binding affinity, meaning a single missed dose produces a smaller relative drop in progestational activity 10.
Micronized progesterone's shorter effective half-life and weaker receptor binding make consistent daily dosing more important. This is a tradeoff: you get a more physiologic hormone with fewer metabolic side effects, but less room for dosing errors.
The E3N cohort study (N=80,377 postmenopausal French women) found that micronized progesterone was associated with no significant increase in breast cancer risk (RR 1.00 to 95% CI 0.83 to 1.22) over a mean follow-up of 8.1 years, while synthetic progestins carried elevated risk 11. That safety profile is one reason prescribers accept the tighter dosing discipline micronized progesterone requires.
When to Call Your Prescriber About Missed Doses
Not every skipped capsule warrants a phone call. Here is a practical threshold.
Call if:
- You missed 2 or more consecutive doses in a cyclic regimen
- You missed 3 or more consecutive doses on continuous therapy
- You notice unexpected vaginal bleeding after a missed dose (this may signal incomplete endometrial suppression)
- You are unsure whether to restart mid-cycle or wait for the next cycle
No call needed if:
- You missed one dose and took it the next morning
- You skipped one dose entirely and resumed the following bedtime
- You are on continuous dosing and missed a single night
The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 141 recommends that "patients on cyclic progestogen therapy who miss multiple doses should be evaluated for endometrial adequacy before restarting, particularly if they have risk factors for endometrial neoplasia" 12.
Strategies to Avoid Missing Doses
The most common reason women miss Prometrium is that bedtime routines vary. Travel, shifting sleep schedules, and the capsule's peanut oil base (which requires specific storage) all contribute.
Set a consistent alarm. The sedative effect means taking Prometrium at 10:30 PM when you plan to sleep at 11 PM is ideal, but 9 PM or midnight works as long as the time does not shift by more than 2 hours night to night.
Store capsules at room temperature (20 to 25°C). High heat degrades micronized progesterone's peanut oil matrix and may reduce bioavailability 4. Keeping a capsule in a hot car or a bathroom medicine cabinet above a shower is not recommended.
If you have a known peanut allergy, you should not be taking Prometrium at all. The capsule shell contains peanut oil, and the FDA labeling includes a contraindication for peanut hypersensitivity 4. Alternatives include vaginal micronized progesterone (Endometrin, Crinone) or synthetic progestins.
Progesterone Blood Levels: Can You Test Whether a Missed Dose Matters?
A serum progesterone level drawn the morning after a missed dose is not clinically useful for assessing endometrial protection. Oral micronized progesterone produces highly variable serum levels (peak concentrations range from 17 to 47 ng/mL after a 200 mg dose with food), and a single trough measurement cannot predict endometrial response 2.
What does correlate with protection is cumulative exposure over the full cycle. The PEPI trial's endometrial biopsy data confirmed that the 12-day cyclic regimen produced secretory transformation in 95% of participants at 12 months, regardless of individual pharmacokinetic variation 1. The tissue response, not the blood level, is the endpoint that matters.
If your prescriber is concerned about endometrial adequacy after repeated missed doses, an endometrial thickness measurement via transvaginal ultrasound (threshold typically <5 mm in postmenopausal women) or an endometrial biopsy is the appropriate next step 12.
Frequently asked questions
›What happens if I miss one dose of Prometrium?
›Can I take Prometrium in the morning instead of at bedtime?
›How many missed doses of Prometrium are dangerous?
›Should I double my Prometrium dose if I missed one?
›Does missing Prometrium cause breakthrough bleeding?
›How does Prometrium work differently from synthetic progestins?
›What is Prometrium's half-life?
›Does food affect Prometrium absorption?
›Can I take Prometrium if I have a peanut allergy?
›Is 100 mg continuous Prometrium as protective as 200 mg cyclic?
›When should I call my doctor about missed Prometrium doses?
›Can I check my progesterone level to see if a missed dose mattered?
References
- Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273(3):199-208
- de Lignieres B. Oral micronized progesterone. Clin Ther. 1999;21(1):41-60
- Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011
- Prometrium (progesterone, USP) capsules prescribing information. U.S. Food and Drug Administration
- Panay N, Hamoda H, Arya R, Savvas M. The 2013 British Menopause Society & Women's Health Concern recommendations on hormone replacement therapy. Post Reprod Health. 2013;19(2):59-68
- Freeman EW, Rickels K, Sondheimer SJ, Polansky M. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA. 1995;274(1):51-57
- Baber RJ, Panay N, Fenton A; IMS Writing Group. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109-150
- Giudice LC. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril. 1994;61(1):1-17
- Pinkerton JV, Pickar JH. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy. Menopause. 2016;23(2):215-223
- Stanczyk FZ. All progestins are not created equal. Steroids. 2003;68(10-13):879-890
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202-216